An academic medical center's 20+ year partnership with Labcorp continues to deliver quality

An academic medical center's joint venture with Labcorp, initiated more than 20 years ago, has resulted in significant savings for the medical center, as well as access to state-of-the-art equipment and diagnostic testing. The relationship enables the health system to focus on its core mission-patient care-while Labcorp deploys its expertise and industry strength to manage the lab on a daily basis, support new service lines and develop strategic plans for the future.

Four reasons to talk to your patients about colon cancer screening

More than 100 million people in the US are eligible for colon cancer screening, but why are so many of them not following through with testing?1,2 Misconceptions about colon cancer screening—including when it is appropriate and what testing methods are available—are among the leading reasons patients delay screening.3 You can help your patients follow through on their colon cancer screening by discussing their options and educating them on fecal immunochemical testing (FIT).

Circuit Clinical and Pottstown Medical Specialists (PMSI) bring clinical research to 180K+ patients across greater northwest Philadelphia region

BUFFALO, N.Y., June 28, 2022 — Following its mission to transform the way patients find, choose, and experience clinical research, Circuit Clinical - one of the nation's fastest-growing research networks - has partnered with Pottstown Medical Specialists (PMSI) - a leading primary care and specialty services physician network - to bring clinical research as a care option close to home for over 180,000 residents across the area's Montgomery and Berks counties. Clinical trial opportunities will be provided by Labcorp, a global life sciences company.

Laura Gillim-Ross, PhD

Dr Gillim-Ross is discipline director for infectious disease immunology at Labcorp and a director in the Department of Science and Technology in Burlington. She previously served as the Technical Director for the Denver Regional Laboratory.

3 key differences between medical screening and diagnostic testing

Since the beginning of the COVID-19 pandemic, the world has become increasingly aware of the importance of testing in healthcare. However, it is important to know the difference between diagnostic testing and screening. Both can help save lives, but screening and diagnostic tests have different use cases and may need to be used together to create an overall picture of your health.

Five ways the pandemic has changed healthcare for the better

Year three of the pandemic has brought its fair share of challenges, but it has also highlighted some positive and impactful changes in healthcare. We’ve identified five ways our healthcare has adapted and improved for the better since the start of the COVID-19 pandemic.

Why confirming your rapid antigen COVID-19 test results with a PCR test is important

At this point, we all probably have either had COVID-19 ourselves or known someone close to us who has had it. Since March 2020, nearly 80 million U.S. residents have had confirmed COVID-19 infections – and many more likely have been infected but without reported tests to confirm. And we’re still battling variants and mutations of the disease.

Why viral variants like omicron are emerging: A viral variation 101

When the COVID-19 pandemic started, we had a singular enemy: the SARS-CoV-2 virus. However, now it seems that there are multiple enemies, with the emergence of variants like Delta and Omicron. How did this happen?

Labcorp to offer risk-scoring test for people with advanced liver fibrosis due to NASH

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 26, 2022-- For the millions of people in the United States living with an advanced form of chronic liver disease, simply understanding the potential for future complications could help stave off severe damage and even a transplant. Labcorp (NYSE: LH), a leading global life sciences company, is making this possible by offering the Enhanced Liver Fibrosis (ELF™) test. Developed by Siemens Healthineers, the physician-ordered blood test helps assess the risk of disease progression in individuals—opening the door for improved outcomes. The test has been granted De Novo marketing authorization by the U.S. Food and Drug Administration .

Ovia Health and CDPHP: Supporting healthy parenthood for members

Cardiff, UK, March 3, 2021 ‒ TrakCel, a leading supplier of cellular orchestration solutions supporting the cell and gene therapy industry, today announces that it has closed its latest funding round led by AmerisourceBergen and Labcorp (NYSE: LH). These strategic investments enable further transformation of TrakCel’s cellular therapy orchestration solution, growth of its existing partner ecosystem, and continued global expansion.